The societal benefit of nonprofit biotechnology companies
Clin Adv Hematol Oncol
.
2008 May;6(5):366-7, 386.
Author
Rena M Conti
1
Affiliation
1
Section of Pediatric Hematology/Oncology, Center on Health and the Social Sciences, Program on Pharmaceutical Policy, Cancer Research Center, University of Chicago, Chicago, IL, USA.
PMID:
18516026
PMCID:
PMC4637938
No abstract available
MeSH terms
Biotechnology / economics*
Drug Design
Humans
Neoplasms / drug therapy
Organizations, Nonprofit / organization & administration*
Research / economics*
Research Support as Topic
Social Responsibility
Grants and funding
K07 CA138906/CA/NCI NIH HHS/United States